394 related articles for article (PubMed ID: 24904174)
1. Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance.
Guo W
Stem Cells Transl Med; 2014 Aug; 3(8):942-8. PubMed ID: 24904174
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNAs in the regulation of breast cancer stem cells.
Liu S; Clouthier SG; Wicha MS
J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
[TBL] [Abstract][Full Text] [Related]
3. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
[TBL] [Abstract][Full Text] [Related]
5. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
[TBL] [Abstract][Full Text] [Related]
6. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
7. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
9. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
Yeeravalli R; Kaushik K; Das A
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
[TBL] [Abstract][Full Text] [Related]
10. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.
Lu H; Clauser KR; Tam WL; Fröse J; Ye X; Eaton EN; Reinhardt F; Donnenberg VS; Bhargava R; Carr SA; Weinberg RA
Nat Cell Biol; 2014 Nov; 16(11):1105-17. PubMed ID: 25266422
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
13. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.
Louie E; Nik S; Chen JS; Schmidt M; Song B; Pacson C; Chen XF; Park S; Ju J; Chen EI
Breast Cancer Res; 2010; 12(6):R94. PubMed ID: 21067584
[TBL] [Abstract][Full Text] [Related]
14. EMT in breast cancer stem cell generation.
Ansieau S
Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
[TBL] [Abstract][Full Text] [Related]
15. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.
Hong D; Fritz AJ; Zaidi SK; van Wijnen AJ; Nickerson JA; Imbalzano AN; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2018 Dec; 233(12):9136-9144. PubMed ID: 29968906
[TBL] [Abstract][Full Text] [Related]
17. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
[TBL] [Abstract][Full Text] [Related]
18. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.
Hollier BG; Tinnirello AA; Werden SJ; Evans KW; Taube JH; Sarkar TR; Sphyris N; Shariati M; Kumar SV; Battula VL; Herschkowitz JI; Guerra R; Chang JT; Miura N; Rosen JM; Mani SA
Cancer Res; 2013 Mar; 73(6):1981-92. PubMed ID: 23378344
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.
Takebe N; Warren RQ; Ivy SP
Breast Cancer Res; 2011 Jun; 13(3):211. PubMed ID: 21672282
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
Bosukonda A; Carlson WD
Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]